Literature DB >> 1433373

Serum interleukin-6 levels in metastatic renal cell cancer: correlation with survival but not an independent prognostic indicator.

W M Stadler, J M Richards, N J Vogelzang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1433373     DOI： 10.1093/jnci/84.23.1835

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  9 in total

Review 1.  Growth factors and renal cancer: characterization and therapeutic implications.

Authors:  J H Mydlo
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

2.  Expression of the interleukin 6 receptor in primary renal cell carcinoma.

Authors:  V Costes; J Liautard; M C Picot; M Robert; N Lequeux; J Brochier; P Baldet; J F Rossi
Journal:  J Clin Pathol       Date:  1997-10       Impact factor: 3.411

3.  Prognostic role of interleukin-6 in renal cell carcinoma: a meta-analysis.

Authors:  Y Wang; Y Zhang
Journal:  Clin Transl Oncol       Date:  2019-08-13       Impact factor: 3.405

Review 4.  Biology of metastasis and its clinical implications: renal-cell cancer.

Authors:  J C Ulchaker; E A Klein
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

5.  Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker.

Authors:  J S Goydos; A M Brumfield; E Frezza; A Booth; M T Lotze; S E Carty
Journal:  Ann Surg       Date:  1998-03       Impact factor: 12.969

6.  Treatment of metastatic renal cell carcinoma with subcutaneous interleukin 2: evidence for non-renal clearance of cytokines.

Authors:  R E Banks; M A Forbes; S Hallam; A Jenkins; M Wadhwa; P Dilger; A Meager; R Thorpe; C J Bowmer; J K Joffe; P Patel; P W Johnson; P J Selby
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Interleukin-6, tumour necrosis factor alpha and interleukin-1beta in patients with renal cell carcinoma.

Authors:  N Yoshida; S Ikemoto; K Narita; K Sugimura; S Wada; R Yasumoto; T Kishimoto; T Nakatani
Journal:  Br J Cancer       Date:  2002-05-06       Impact factor: 7.640

8.  Recombinant human interleukin 6 in metastatic renal cell cancer: a phase II trial.

Authors:  J M Stouthard; H Goey; E G de Vries; P H de Mulder; A Groenewegen; L Pronk; G Stoter; H P Sauerwein; P J Bakker; C H Veenhof
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

9.  Prognostic value of interleukin-6 and interleukin-6 receptor in organ-confined clear-cell renal cell carcinoma: a 5-year conditional cancer-specific survival analysis.

Authors:  Qiang Fu; Yuan Chang; Huimin An; Hangcheng Fu; Yu Zhu; Le Xu; Weijuan Zhang; Jiejie Xu
Journal:  Br J Cancer       Date:  2015-11-10       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.